Theranos CEO forfeits control, pays $500,000 to settle charges linked to‘massive fraud’

Elizabeth Holmes’ settlement comes two years after the Securities and Exchange Commission began looking into claims at Theranos that it had developed potentially revolutionary blood-testing technology.